These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer]. Liu ZZ, Lu ZD, Zhang HW, Yang H, Liu H, Li LF, Li WL, Cui SD. Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):544-6. PubMed ID: 22093636 [Abstract] [Full Text] [Related]
3. In Vivo Detection of Multidrug-Resistance Related Proteins in Locally Advanced Breast Cancer Using 99mTc-MIBI SPECT/CT Imaging: Correlation with Clinical Outcomes. Mostafa NM, Elnaggar MS, Abdelhafez YG, Rezk K, Sherif MF, Eltyb HA, Ahmed S, Abu Elnga NE, Hussien MT. Asian Pac J Cancer Prev; 2024 Sep 01; 25(9):3125-3141. PubMed ID: 39342592 [Abstract] [Full Text] [Related]
4. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma. Maini CL, Tofani A, Sciuto R, Semprebene A, Cavaliere R, Mottolese M, Benevolo M, Ferranti F, Grandinetti ML, Vici P, Lopez M, Botti C. J Nucl Med; 1997 Oct 01; 38(10):1546-51. PubMed ID: 9379190 [Abstract] [Full Text] [Related]
6. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study. Kurata S, Ushijima K, Kawahara A, Kaida H, Kawano K, Hirose Y, Kage M, Kamura T, Ishibashi M, Abe T. Ann Nucl Med; 2015 Aug 01; 29(7):643-9. PubMed ID: 25921216 [Abstract] [Full Text] [Related]
8. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer. Kawata K, Kanai M, Sasada T, Iwata S, Yamamoto N, Takabayashi A. Clin Cancer Res; 2004 Jun 01; 10(11):3788-93. PubMed ID: 15173086 [Abstract] [Full Text] [Related]
9. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography. Mezi S, Primi F, Capoccetti F, Scopinaro F, Modesti M, Schillaci O. Int J Oncol; 2003 Jun 01; 22(6):1233-40. PubMed ID: 12738988 [Abstract] [Full Text] [Related]
14. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer. Alonso O, Delgado L, Núñez M, Vargas C, Lopera J, Andruskevicius P, Sabini G, Gaudiano J, Musé IM, Roca R. Nucl Med Commun; 2002 Aug 01; 23(8):765-71. PubMed ID: 12124482 [Abstract] [Full Text] [Related]
16. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours. Jacobsson H, Wilczek B, Bergh J, von Schoultz E, Eriksson E, Larsson SA. Nucl Med Commun; 2006 Apr 01; 27(4):347-52. PubMed ID: 16531920 [Abstract] [Full Text] [Related]
17. Dynamic imaging: scintimammography. Salvatore M, Del Vecchio S. Eur J Radiol; 1998 May 01; 27 Suppl 2():S259-64. PubMed ID: 9652532 [Abstract] [Full Text] [Related]
19. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis. Yüksel M, Cermik TF, Doğanay L, Karlikaya C, Cakir E, Salan A, Berkarda S. Eur J Nucl Med Mol Imaging; 2002 Jul 01; 29(7):876-81. PubMed ID: 12111127 [Abstract] [Full Text] [Related]
20. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients. Fallahi B, Beiki D, Mousavi SA, Gholamrezanezhad A, Eftekhari M, Fard-Esfahani A, Alimoghaddam K, Mirpour S, Eskandarian A, Saghari M. Hell J Nucl Med; 2009 Jul 01; 12(3):255-9. PubMed ID: 19936339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]